Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 465 entries
View as:

A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX

Phase: N/A Priority: Normal
NCT ID: NCT00034788 Org: User:
Start: 12/31/00 End: 02/29/04 Due: 02/28/05

The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00034749 Org: User:
Start: 04/30/01 End: 03/31/06 Due: 03/31/07

Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00076115 Org: User:
Start: 12/31/03 End: 12/31/05 Due: 12/31/06

Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis

Phase: N/A Priority: Normal
NCT ID: NCT00210990 Org: User:
Start: 03/31/04 End: 04/30/06 Due: 04/30/07

A Pilot Study of Topiramate in Childhood Absence Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00210574 Org: User:
Start: 03/31/05 End: 10/31/06 Due: 10/31/07

Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)

Phase: N/A Priority: Normal
NCT ID: NCT01545778 Org: User:
Start: 02/28/10 End: 02/29/12 Due: 02/28/13

A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01068223 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11

An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00455429 Org: User:
Start: 04/30/07 End: 03/31/09 Due: 03/31/10

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00074477 Org: User:
Start: 10/31/03 End: 07/31/04 Due: 07/31/05

A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01177150 Org: User:
Start: 11/30/06 End: 04/30/07 Due: 04/30/08

Bioequivalence Study of Patches With Different Equilibration Profiles

Phase: N/A Priority: Normal
NCT ID: NCT00775086 Org: User:
Start: 05/31/04 End: 08/31/04 Due: 08/31/05

A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses

Phase: N/A Priority: Normal
NCT ID: NCT00249210 Org: User:
Start: 08/31/93 End: 07/31/94 Due: 07/31/95

Bioavailability Study of Folic Acid in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT00709267 Org: User:
Start: 10/31/04 End: 12/31/04 Due: 12/31/05

A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)

Phase: N/A Priority: Normal
NCT ID: NCT01787357 Org: User:
Start: 06/30/08 End: 09/30/08 Due: 09/30/09

A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT00034775 Org: User:
Start: 08/31/01 End: 10/31/02 Due: 10/31/03

A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00297388 Org: User:
Start: - End: 09/30/04 Due: 09/30/05

A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women

Phase: N/A Priority: Normal
NCT ID: NCT00915668 Org: User:
Start: - End: 03/31/11 Due: 03/31/12

A Single and Multiple Dose Study of Canagliflozin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01281579 Org: User:
Start: 01/31/11 End: 04/30/11 Due: 04/30/12

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050141 Org: User:
Start: 09/30/02 End: 01/31/08 Due: 01/31/09

A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00806247 Org: User:
Start: 01/31/05 End: 08/31/05 Due: 08/31/06

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

Phase: N/A Priority: Normal
NCT ID: NCT00391287 Org: User:
Start: 06/30/06 End: 12/31/10 Due: 12/31/11

A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion

Phase: N/A Priority: Normal
NCT ID: NCT00695396 Org: User:
Start: 06/30/08 End: 01/31/10 Due: 01/31/11

A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT00518323 Org: User:
Start: 08/31/07 End: 03/31/09 Due: 03/31/10

A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01718652 Org: User:
Start: 02/28/11 End: 04/30/11 Due: 04/30/12

A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04330248 Org: User:
Start: 03/31/20 End: 06/14/22 Due: 06/14/23